What is BDX's health score?

BECTON DICKINSON & CO (BDX) has a TradeApes health score of 57 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BDX's estimated fair value?

Based on our 5-year discounted cash flow model, BECTON DICKINSON & CO's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is BDX undervalued or overvalued?

Our model currently rates BDX as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BDX... Refresh in a moment for the full analysis.

BECTON DICKINSON & CO (BDX)

Healthcare Overvalued low mixed

$151.16

Updated: 2026-06-06

TradeApes Score

Financial Strength

30 Weak

Operating Trend

50 Mixed

Relative Value

75 Strong

Capital Allocation

65 Healthy

Risk

80 Strong

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− High leverage — net debt/EBITDA between 3× and 5×

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.